Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Washington University School of Medicine
Pfizer
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Novartis
Novartis
National Cancer Institute (NCI)
Scripps Health
Amgen